Customer concentration
A single U.S. customer accounted for a large share of revenue, making results volatile.
- Scope
- Historically largest customer
- Materiality
- high
Sensus Healthcare, Inc.
Sensus Healthcare, Inc. is a U.S.-based medical device company focused on non-invasive treatment of non-melanoma skin cancer and post-surgical keloid scar prevention. Its core platform is superficial radiation therapy (SRT), delivered through the SRT-100, SRT-100+ and SRT-100 Vision systems, with operations run as a single segment from Boca Raton, Florida.
−36,0 %
43,2 %
−28,1 %
−34,3 %
9.72
6.63
| % | |
|---|---|
| SRT treatment systems | 65% Superficial radiation therapy devices used to treat non-melanoma skin cancer and keloids. |
| Fair Deal Agreement | 20% Recurring revenue model where Sensus provides equipment and clinical support in exchange for a share of reimbursement. |
| Sentinel service program | 8% Maintenance and support contracts covering parts, labor, preventive maintenance, and installation-related services. |
| Consumables | 5% Disposable shielding, safety items, probe film, and applicator tips used with SRT treatments. |
| Other services and legacy products | 2% Operational healthcare services and limited legacy distribution of aesthetic laser devices. |
Sensus sells primarily to dermatology clinics, independent medical practices, and corporate accounts that treat skin...
- Dermatology clinicsprimary
Buy SRT systems and services to treat non-melanoma skin cancer and keloids in outpatient settings.
- Independent medical practicesprimary
Purchase systems or use financing/service models to add a reimbursable skin-treatment capability.
- Corporate accountssecondary
Acquire multiple systems or standardized service packages across clinic networks.
- Fair Deal Agreement userssecondary
Access SRT through a revenue-share arrangement rather than an upfront purchase.
- Existing installed-base customerssecondary
Buy consumables, maintenance, and support to keep installed systems operating.
Sensus operates globally but is heavily concentrated in the United States, which accounted for 92% of sales in 2025 and...
- •U.S. sales dominate the business and drive most revenue
- •Installed base spans 21 countries, mainly outside the U.S. as a smaller footprint
- •International presence supports future expansion but is not the main revenue base
- •Boca Raton, Florida is the corporate headquarters and operating center
- •Geographic concentration increases exposure to U.S. reimbursement and demand shifts
Sensus is focused on expanding adoption of its SRT platform through reimbursement support, direct sales, and...
01
Expand reimbursement-supported adoptionshort-term
Coverage and reimbursement are central to physician and clinic willingness to use SRT.
02
Grow recurring and service-linked revenuemedium-term
Service contracts and revenue-share models can stabilize customer relationships and improve retention.
03
Reduce purchase frictionshort-term
Financing and leasing alternatives can convert prospects that are sensitive to upfront capital cost.
04
Increase installed-base utilitymedium-term
Software and connectivity can make existing systems more valuable and support repeat usage.
Sensus is exposed to reimbursement risk because demand for its procedures depends on coverage and payment levels from...
Third-party reimbursement risk
Physicians and clinics may not adopt SRT if payors do not cover procedures adequately.
- Scope
- U.S. Medicare, Medicaid, and private insurers
- Materiality
- high
Geographic concentration
Most sales come from the U.S., so domestic demand shifts have outsized impact.
- Scope
- United States
- Materiality
- high
Single-source supplier dependence
The company relies on a preferred supplier for x-ray tubes and other major components.
- Scope
- Key components for SRT systems
- Materiality
- high
Regulatory and litigation risk
Medical device companies face FDA oversight, enforcement, and patent disputes.
- Scope
- Class II devices and skin cancer treatment market
- Materiality
- medium
Revenue recognition
Can shift revenue between periods and affect comparability
Fair Deal Agreement accounting
Affects reported revenue mix and margin profile
Deferred revenue and service obligations
Impacts balance sheet liabilities and future revenue recognition
Income tax estimates and credits
Can cause volatility in tax expense and net income
Inventory and supply chain commitments
Can affect working capital and inventory valuation
: 29.4.2026